127 related articles for article (PubMed ID: 2706526)
1. Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study.
Atack JR; Wenk GL; Wagster MV; Kellar KJ; Whitehouse PJ; Rapoport SI
Brain Res; 1989 Apr; 483(2):367-72. PubMed ID: 2706526
[TBL] [Abstract][Full Text] [Related]
2. Effects of nucleus basalis lesion on muscarinic receptor subtypes.
Bogdanovic N; Islam A; Nilsson L; Bergström L; Winblad B; Adem A
Exp Brain Res; 1993; 97(2):225-32. PubMed ID: 8150042
[TBL] [Abstract][Full Text] [Related]
3. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
[TBL] [Abstract][Full Text] [Related]
4. Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of [3H]acetylcholine release in the rat cerebral cortex.
Meyer EM; Arendash GW; Judkins JH; Ying L; Wade C; Kem WR
J Neurochem; 1987 Dec; 49(6):1758-62. PubMed ID: 3681294
[TBL] [Abstract][Full Text] [Related]
5. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections.
Spencer DG; Horváth E; Traber J
Brain Res; 1986 Aug; 380(1):59-68. PubMed ID: 3756473
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
7. Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex.
Norman AB; Blaker SN; Thal L; Creese I
Neurosci Lett; 1986 Oct; 70(2):289-94. PubMed ID: 3774231
[TBL] [Abstract][Full Text] [Related]
8. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis.
Lapchak PA; Araujo DM; Pasinetti G; Hefti F
Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography.
Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
Neuroscience; 1992; 47(2):367-93. PubMed ID: 1641129
[TBL] [Abstract][Full Text] [Related]
10. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
11. Parallel postnatal development of choline acetyltransferase activity and muscarinic acetylcholine receptors in the rat olfactory bulb.
Large TH; Lambert MP; Gremillion MA; Klein WL
J Neurochem; 1986 Mar; 46(3):671-80. PubMed ID: 3754001
[TBL] [Abstract][Full Text] [Related]
12. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
13. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
Tilson HA; Schwartz RD; Ali SF; McLamb RL
Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
[TBL] [Abstract][Full Text] [Related]
14. Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain.
Quirion R
Synapse; 1987; 1(4):293-303. PubMed ID: 3138770
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
17. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
18. Ontogeny of cortical muscarinic receptor subtypes and muscarinic receptor-mediated responses in rat.
Lee W; Nicklaus KJ; Manning DR; Wolfe BB
J Pharmacol Exp Ther; 1990 Feb; 252(2):482-90. PubMed ID: 2156047
[TBL] [Abstract][Full Text] [Related]
19. Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey.
Wagster MV; Whitehouse PJ; Walker LC; Kellar KJ; Price DL
J Neurosci; 1990 Sep; 10(9):2879-85. PubMed ID: 2398366
[TBL] [Abstract][Full Text] [Related]
20. GTP effects in rat brain slices support the non-interconvertability of M1 and M2 muscarinic acetylcholine receptors.
Spencer DG; Horváth E; Traber J; Van Rooijen LA
Life Sci; 1988; 42(9):993-7. PubMed ID: 3343895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
